Navigation Links
Biologists merge methods, results from different disciplines to find new meaning in old data
Date:1/11/2010

Durham, NC A growing number of scientists are merging methods and results from different disciplines to extract new meaning from old data, says a team of researchers in a recent issue of Evolution.

As science becomes increasingly specialized and focused on new data, however, researchers who want to analyze previous findings may have a hard time getting funding and institutional support, the authors say. In a commentary piece in the journal Evolution, the authors argue for removing cultural and technological barriers to this process.

"By putting together pieces of prior research, it is possible to transform how you do science and open the doors to findings that previously were unattainable," said Brian Sidlauskas, a former postdoctoral researcher at the National Evolutionary Synthesis Center and lead author on the article. "But such an approach runs counter to the way science traditionally has been conducted, so pursuing synthetic science is somewhat risky."

"We need to reduce the risk, remove the barriers, and encourage more pursuit of synthesis," said Sidlauskas, now a professor at Oregon State University. "The potential is staggering," he added.

Some of the most important research of the last quarter-century, the authors argue, has resulted from "synthetic science" an approach which combines concepts, tools, and data from multiple disciplines to produce new insights or discoveries.

They cite the work of J. John Sepkoski Jr., who over a 20-year period compiled a database of more than 37,000 entries tracking the first and last appearance of different organisms in the fossil record. The entries, they write, "cut across taxa, time, and geography to reveal emergent patterns over more than 500 million years of life that could not be extracted from the component data in isolation."

"That database led to previously undetermined knowledge of five separate mass extinctions through time, understand
'/>"/>

Contact: Brian Sidlauskas
brian.sidlauskas@oregonstate.edu
541-737-1939
National Evolutionary Synthesis Center (NESCent)
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New handbook for biologists who need more competence or confidence in statistics
2. Biologists discover bacterial defense mechanism against aggressive oxygen
3. Beyond genomics, biologists and engineers decode the next frontier
4. Biologists, educators recognize excellence in evolution education
5. NIMBioS hosts tutorial on optimal control and optimization for biologists
6. Biologists discover death stench is a universal ancient warning signal
7. UTSA plant biologists publish where their peers are -- on the Web
8. Microbiologists find defense molecule that senses respiratory viruses
9. Geobiologists propose that the earliest complex organisms fed by absorbing ocean buffet
10. Biologists rediscover endangered frog population
11. Smaller plants punch above their weight in the forest, say Queens biologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... aimed at improving the food intake, health and quality ... is among three projects at the University of Waterloo ... Canadian Institutes of Health Research (CIHR). , Professor ... at Waterloo, and a Schlegel research chair in nutrition ... investigate why many Canadians living in long-term care homes ...
(Date:8/21/2014)... Wednesday, Oct. 18-22, 2014 , WHERE: , ... San Diego, CA 92101 , WHAT: , ... of the latest research in human genetics. Examples ... high-scoring abstracts on rare genetic variants in health ... treatment for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2
... (UW) have reported for the first time that mammals can ... retinas. Located in the back of the eye, the retina,s ... to the brain. The findings on retina self-repair in ... of the Proceedings of the National Academy of Sciences ...
... Institute of Technology has invited a longtime University of ... and presenting seminars on its campus. Fazle Hussain, ... Engineering, was the sole recipient of the Gordon and ... for Caltech,s division of engineering and applied sciences. The ...
... University have answered a fundamental question of how important ... function, a finding that could provide a new target ... diseases. In a study published this month in ... show for the first time that the specific movements ...
Cached Biology News:Mammals can be stimulated to regrow damaged inner retina nerve cells 2Mammals can be stimulated to regrow damaged inner retina nerve cells 3Celebrated UH researcher invited to Caltech as distinguished scholar 2Scientists present 'moving' theory behind bacterial decision-making 2
(Date:8/21/2014)... (PRWEB) August 21, 2014 Pursuit ... selling optimization technology and services for Life Sciences ... “Grading Pharma’s Use of New Commercial Sales Models” ... & Analytics. , The article examines some innovative ... that are being tested in the pharmaceutical market. ...
(Date:8/21/2014)... Louis, MO (PRWEB) August 21, 2014 ... full service biopharmaceutical contract development and manufacturing organization ... by Progenics Pharmaceuticals, Inc., an oncology company focused ... and treating cancer, to manufacture the anti-prostate specific ... PSMA ADC product candidate. Under the agreement ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, ... Signaling molecules, became available for purchase in Australia and New ... that RENU 28 works is, if you think about the ... rate of cellular renewal within your body. If you think ... rate of cellular renewal. What RENU 28 does is it ...
(Date:8/20/2014)... An analysis of patented university inventions licensed to ... path to commercialization. To open these roadblocks, the ... results during the discovery stage could lead to ... are frequently derived from discoveries made in university ... well known during clinical trials, which have a ...
Breaking Biology Technology:Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3RENU 28 Skin Care Now Available in Australia and New Zealand 2Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3
... DRRX ) announced today that a New ... submitted to the U.S. Food,and Drug Administration (FDA). ... formulation of oxycodone intended to treat moderate to ... designed to resist,common methods of prescription drug misuse ...
... to advance Merrimack,s robust pipeline of biologics ... targeting autoimmune disease and cancer, CAMBRIDGE, Mass., ... the discovery and development of,novel treatments for autoimmune disease and ... Series F private equity financing., Existing and new investors ...
... Bioheart, Inc.,(Nasdaq: BHRT ) today announced that ... common stock to the Nasdaq Capital Market. The Company,s,common ... to The,Nasdaq Capital Market at the opening of business ... a tier of the Nasdaq Stock Market for,companies with ...
Cached Biology Technology:New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 2New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 3New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 4New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone) 5Merrimack Pharmaceuticals Raises $60 Million in Private Financing 2Bioheart, Inc. to Transfer to Nasdaq Capital Market 2
Human Cystatin F MAb (Clone 292103)...
... Ac-DEVD-CHO is an inhibitor ... The concentration of inhibitor ... activity must be determined ... Ten micromolar inhibitor is ...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
Mouse NOV/CCN3 Affinity Purified Polyclonal Ab...
Biology Products: